Can Lumbar Mulligan Mobilization Improve Gait, Balance, and Trunk Position Sense After Stroke?
Launched by GULHANE SCHOOL OF MEDICINE · Mar 14, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a specific treatment called Mulligan mobilization, which focuses on the lower back, can help improve balance, walking ability, and trunk awareness in people who have had a stroke. After a stroke, many individuals face difficulties with movement and balance, which can lead to a higher risk of falls and impact their daily activities. The goal of this study is to see if adding this new approach to traditional rehabilitation exercises can enhance recovery and help stroke survivors regain their independence.
To participate in the trial, candidates must be between 30 and 65 years old, have experienced their first stroke within the last 6 to 24 months, and have certain scores on specific assessments that evaluate their recovery level. However, individuals with certain spine issues, previous back surgeries, or other neurological conditions like Parkinson's disease are not eligible. Participants in the study can expect to engage in specialized exercises aimed at improving their balance and movement, and they will be closely monitored throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants must meet all of the following conditions to be eligible for the study:
- • Diagnosed with stroke by a neurologist.
- • Aged 30 to 65 years.
- • First-ever stroke (single episode).
- • Stroke duration between 6 to 24 months.
- • Score of ≤3 on the Modified Rankin Scale (mRS).
- • Score of ≥24 on the Mini-Mental State Examination (MMSE).
- Exclusion Criteria:
- * Participants will be excluded if they meet any of the following conditions:
- • History of musculoskeletal disorders affecting the spine (e.g., cancer, scoliosis, spondylolisthesis, rheumatoid arthritis, ankylosing spondylitis).
- • Previous lumbar spine surgery.
- • Presence of neurological conditions other than stroke (e.g., Parkinson's disease, multiple sclerosis).
- • Severe visual impairment affecting balance or walking.
About Gulhane School Of Medicine
Gulhane School of Medicine is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the school fosters a collaborative environment where multidisciplinary teams work to explore new treatment modalities and enhance medical knowledge. By engaging in rigorous clinical research, Gulhane School of Medicine aims to contribute to the development of effective therapies and improve health outcomes, ultimately benefitting both the local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported